Open Now: The Global ETF Survey Take the Survey →

Advertisement
Advertisement

IBBQvsIHEETF Comparison

ETF 1
IBBQ

Invesco Nasdaq Biotechnology ETF

This fund is part of
US Health Care
+1.78%
VS
ETF 2
IHE

iShares U.S. Pharmaceuticals ETF

This fund is part of
US Health Care
+1.78%

Invesco Nasdaq Biotechnology ETF (IBBQ) and iShares U.S. Pharmaceuticals ETF (IHE) belong to the same industry segment: US Health Care. IBBQ's top 3 sector exposures are Healthcare and Non-Energy Materials. In contrast, IHE's top sector exposures are Healthcare and Non-Corporate. IBBQ is less expensive with a Total Expense Ratio (TER) of 0.19%, versus 0.38% for IHE. IBBQ is up 15.65% year-to-date (YTD) with +$3M in YTD flows. IHE performs better with 23.45% YTD performance, and +$578M in YTD flows. Run a side-by-side ETF comparison of IBBQ and IHE below, and assess how they stack up in performance, liquidity, risk, exposure, holdings, and more, helping you select the best ETF for your investments.

Find out how industry players manage ETF portfolios.  Discover our library of Model portfolios

IBBQ vs IHE performance and flow charts

Performance

-2.0-1.00.01.02.03.04.0%Jun 29Jul 7Jul 14Jul 21Jul 28

Cumulative Flows

0 M100 M200 M300 M400 M500 MJun 29Jul 7Jul 14Jul 21Jul 28

Get all the metrics on this page, and more, through a reliable ETF data feed

Daily, global ETF data for advanced analysis or integration into apps (API), from our partner Trackinsight.

Historic performance and flows
Data as of 07/28/2026
1M3MYTD1Y3Y5Y
Perf.
IBBQ
IHE
+0.34%+3.87%
+13.13%+21.63%
+15.65%+23.45%
+47.33%+54.16%
+62.62%+78.34%
+31.41%+76.15%
Flows
IBBQ
IHE
+$4M+$465M
+$3M+$496M
+$3M+$578M
+$23M+$731M
+$39M+$826M
+$3M+$841M
Volatility and drawdown
3M1Y3Y5Y
Volatility
IBBQ
IHE
+22.64%+21.18%
+20.25%+18.06%
+20.25%+16.92%
+21.96%+16.50%
Max drawdown
IBBQ
IHE
-5.97%-4.42%
-8.38%-8.48%
-23.78%-16.04%
-38.09%-16.12%
Max drawdown duration
IBBQ
IHE
21d20d
48d81d
375d210d
1543d669d
Trading data

Create an account to view trading data

Join for free
IBBQ
IHE
Last sale
7/29/2026 at 1:30 PM
$32.41
$103.50
Previous close
07/28/2026
$32.76
$103.96
Consolidated volume
07/28/2026
Average volume
30 days
Average discount or premium
30 days
Average Bid/Ask spread
30 days
Replication quality
Data as of June 30, 2026
1-year trailing difference

Create an account to view replication metrics

Join for free

Create an account to view replication quality

Join for free
IBBQ
IHE
Tracking error
Tracking difference
1 year cumulative return difference
Best
Worst
Daily return difference
Average
Worst
Advertisement
Main metrics
Last update 7/29/2026 at 1:30 PM
Live
Closed
IBBQ
IHE
Last price
$32.41
$103.50
1D performance
-1.06%
-0.44%
AuM$76.61 M$1.64 B
E/R0.19%0.38%
Characteristics
IBBQ
IHE
Management strategyPassivePassive
ProviderInvescoiShares
BenchmarkNASDAQ Biotechnology IndexDow Jones U.S. Select Pharmaceuticals Index
N° of holdings25157
Asset classEquitiesEquities
Trailing 12m distribution yield
Join
Join
Inception dateJune 9, 2021May 1, 2006
ESGNoNo
Advertisement
Exposure

Countries

IBBQ
USA
88.1%
Other
11.9%
IHE
USA
96.01%
Other
3.99%

Sectors

IBBQ
Healthcare
99.98%
Other
0.02%
IHE
Healthcare
99.92%
Other
0.08%
Advertisement

Diversification

IBBQ

Total weight of top 15 holdings out of 15

49.38%
IHE

Total weight of top 15 holdings out of 15

84.53%

Top 15 holdings

Data as of June 30, 2026
IBBQ
Vertex Pharmaceuticals, Inc.
8.16%
Amgen, Inc.
7.91%
Gilead Sciences, Inc.
7.07%
Regeneron Pharmaceuticals, Inc.
4.62%
Alnylam Pharmaceuticals, Inc.
2.76%
Revolution Medicines, Inc.
2.74%
Biogen, Inc.
2.26%
Illumina, Inc.
1.89%
Moderna, Inc.
1.89%
Royalty Pharma Plc
1.77%
Roivant Sciences Ltd.
1.74%
argenx SE
1.73%
United Therapeutics Corp.
1.63%
Incyte Corp.
1.61%
Insmed, Inc.
1.59%
IHE
Johnson & Johnson
22.44%
Eli Lilly & Co.
22.25%
Merck & Co., Inc.
4.55%
Bristol Myers Squibb Co.
4.37%
Royalty Pharma Plc
4.33%
Viatris, Inc.
4.22%
Pfizer Inc.
3.96%
Zoetis, Inc.
3.73%
Jazz Pharmaceuticals Plc
3.45%
Elanco Animal Health, Inc.
2.81%
Axsome Therapeutics, Inc.
2.41%
Corcept Therapeutics, Inc.
1.90%
Ligand Pharmaceuticals, Inc.
1.45%
Definium Therapeutics, Inc.
1.39%
Liquidia Corp.
1.28%
Frequently asked questions about IBBQ and IHE

How have the IBBQ and IHE ETFs performed in 2026?

As of July 28, 2026, IBBQ is up 15.65% year-to-date (YTD), while IHE has returned 23.45%. That puts IHE better performer ahead so far this year.

Which ETF is attracting more investor money: IBBQ or IHE?

Year-to-date, the IBBQ ETF saw +$3M in flows, compared to +$578M for IHE.

Which ETF is more volatile: IBBQ or IHE?

Over the past year, IBBQ had a volatility of 20.25%, while IHE experienced 18.06%.

Which ETF is bigger: IBBQ or IHE?

As of July 28, 2026, IBBQ holds $76.61 M in assets under management (AUM), while IHE manages $1.64 B.

What sectors do the IBBQ and IHE ETFs invest in?

IBBQ leans toward sectors like Healthcare. Meanwhile, IHE focuses on Healthcare.

What are the top holdings of the IBBQ ETF and IHE ETF?

IBBQ top holdings include Vertex Pharmaceuticals, Inc., Amgen, Inc. and Gilead Sciences, Inc.. IHE holds in its top three: Johnson & Johnson, Eli Lilly & Co. and Merck & Co., Inc..

Which ETF is more diversified: IBBQ or IHE?

IBBQ holds 251 securities with 49.38% of its assets in the top 15. IHE has 57 securities and a top 15 weight of 84.53%.

Advertisement
Advertisement
Advertisement
The Active Trader Report

Active Trader Report: Use of Leveraged & Inverse ETFs Way Up

Direxion partnered with Compound Insights and Vanda to explore what’s driving the evolution of active trading — and how active traders are using leveraged and inverse funds across equities, single stocks, commodities, and volatility.

Active Trader Report: Use of Leveraged & Inverse ETFs Way Up